VPN Plus+ ExclusiveRecent Advancements in OncologyJanuary 31, 2024In this session: Craig Clifford, DVM, MS, DACVIM (Oncology), describes the latest in the field of oncology, including a chemotherapy sensitivity assay from Imprimed to help guide drug decisions, a new conditionally approved drug for canine lymphoma called Laverdia CA-1, and the use of the oncoK9 liquid biopsy test from PetDx.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more